SEATTLE GENETICS INC Supply Agreements
14 Contracts & Agreements
- Amendment No. 1 to Commercial Supply Agreement dated June 17, 2022 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Corden Pharma GmbH (Filed With SEC on July 28, 2022)
- Commercial Supply Agreement between Hovione Farmaciencia, SA and Seagen Inc. dated July 1, 2021 (Filed With SEC on October 28, 2021)
- Second Amendment to Commercial Supply Agreement effective as of December 2, 2016 between (Filed With SEC on February 12, 2021)
- First Amendment to Commercial Supply Agreement effective as of January 20, 2014 between (Filed With SEC on February 12, 2021)
- Commercial Supply Agreement dated December 1, 2010 between (Filed With SEC on February 12, 2021)
- Commercial Supply Agreement dated April 2, 2020 between Seattle Genetics, Inc. and Sterling Pharma Solutions Limited (Filed With SEC on July 31, 2020)
- Commercial Supply Agreement dated February 20, 2020 between Seattle Genetics, Inc. and Corden Plankstadt (Filed With SEC on July 31, 2020)
- Commercial Supply Agreement dated June 13, 2019 between Seattle Genetics, Inc. and Esteve Quimica, S.A (Filed With SEC on July 31, 2020)
- Third Amendment to Commercial Supply Agreement effective as of July 1, 2019 between Seattle Genetics, Inc. and SAFC, an operating division of Sigma-Aldrich, Inc (Filed With SEC on October 30, 2019)
- Second Amendmentto SGD-1006 Commercial Supply Agreement executed on 1 December 2010 and First Amendment to Commercial Supply Agreement executed on 20 January 2014 (the First... (Filed With SEC on February 21, 2017)
- Amendment to SGD-1006 Commercial Supply Agreement executed on 1 December 2010. [*] Manufacturing Controls Price Increase (Filed With SEC on February 21, 2017)
- EIGHTH AMENDMENT TODEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on July 30, 2015)
- COMMERCIAL SUPPLY AGREEMENT SGD-1006 (Filed With SEC on November 4, 2011)
- MANUFACTURING AND SUPPLY AGREEMENT BETWEEN (Filed With SEC on August 9, 2005)
